WB result of Lamin A/C Recombinant Rabbit mAb (HRP Conjugate)
Primary antibody: Lamin A/C Recombinant Rabbit mAb (HRP Conjugate) at 1/10000 dilution
Lane 1: HeLa whole cell lysate 20 µg
Lane 2: HUVEC whole cell lysate 20 µg
Lane 3: HepG2 whole cell lysate 20 µg
Predicted MW: 64, 74 kDa
Observed MW: 60, 74 kDa
Product Details
Product Details
Product Specification
Host | Rabbit |
Antigen | Lamin A/C |
Synonyms | Prelamin-A/C; 70 kDa lamin, Renal carcinoma antigen NY-REN-32; LMN1; LMNA |
Location | Nucleus |
Accession | P02545 |
Clone Number | SDT-R041 |
Antibody Type | Recombinant mAb |
Isotype | IgG |
Application | WB |
Reactivity | Hu |
Positive Sample | HeLa, HUVEC, HepG2 |
Purification | Protein A |
Concentration | 2 mg/ml |
Conjugation | HRP |
Physical Appearance | Liquid |
Storage Buffer | PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300 |
Stability & Storage | 12 months from date of receipt / reconstitution, -20 °C as supplied. |
Dilution
application | dilution | species |
WB | 1:5000-1:10000 | Hu |
Background
Lamin A/C is a crucial nuclear protein encoded by the LMNA gene, playing a significant role in maintaining the structural integrity of the cell nucleus. It is part of the nuclear lamina, a fibrous layer that provides support to the nuclear envelope and helps in organizing the chromatin. Beyond its structural function, lamin A/C is involved in various cellular processes, including gene regulation, DNA replication and repair, cell differentiation, and mechanosensing. Mutations in the lamin A/C gene can lead to a range of diseases collectively known as laminopathies, which include muscular dystrophy, lipodystrophy, and certain forms of cardiomyopathy. Additionally, lamin A/C has been implicated in cancer, where its deregulation can contribute to genomic instability and affect the mechanical resilience of tumor cells.
Picture
Picture
Western Blot
